Diversified Subsidiary Companies Presentation
Adjusted EBITDA Reconciliation by Segment - Year Ended December 31, 2023
($Millions)
Adjusted EBITDA:
Food
(1)
Investment
Energy
Automotive
Packaging
Real
Estate
Home
Fashion
(1)
(1)
Pharma
Holding
Company
Consolidated
Net (loss) income
Interest expense, net
(1,353)
831
(6)
13
16
(6)
(3)
52
12
1
(1)
(504)
189
($1,012)
253
Income tax expense (benefit)
189
(10)
4
(93)
90
Depreciation and amortization
363
81
25
13
7
28
1
518
EBITDA before non-controlling interests
($1,353)
$1,435
$65
$54
$29
$2
$24
($407)
($151)
Impairment
7
7
Credit loss on related party note receivable
139
139
Loss on deconsolidation of subsidiary
246
246
Restructuring costs
1
1
(Gain) loss on disposition of assets, net
(10)
Transformation costs
དྨེཝ
(10)
41
41
Net (gain) loss on extinguishment of debt
(13)
(13)
Out of period adjustments
10
10
Other
11
Adj. EBITDA before non-controlling interests
($1,353)
$1,435
$113
$65
(1)
$28
1
11
$3
$25
($35)
$281
Adjusted EBITDA attributable to IEP:
Net (loss) income
46
Interest expense, net
Income tax expense (benefit)
-
(701)
508
(6)
12
16
(6)
(3)
(504)
($684)
24
11
1
(1)
189
224
135
(10)
4
(93)
36
Depreciation and amortization
202
81
22
13
7
28
1
354
EBITDA attributable to IEP
($701)
$869
$65
$49
$29
$2
$24
($407)
($70)
Impairment
7
7
Credit loss on related party note receivable
139
139
Loss on deconsolidation of subsidiary
246
246
Restructuring costs
1
1
(Gain) loss on disposition of assets, net
Transformation costs
(10)
41
(10)
41
Net (gain) loss on extinguishment of debt
(13)
(13)
Out of period adjustments
10
10
Other
10
(1)
1
10
Adjusted EBITDA attributable to IEP
($701)
$869
$113
$59
$28
$3
$25
($35)
$361
(1) The presentation of Adjusted EBITDA for "All Other Operating Segments" included in this presentation consists of results from our Food Packaging, Home Fashion, and Pharma segments.
23View entire presentation